marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Aptevo Therapeutics Income Statement 2011-2024 | APVO
Annual Income Statement Aptevo Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.59 M | 9.69 M | 36.9 M | 108 M | 25.7 M | 32 M | 72.5 M | 41.1 M | - | - | - | - | - |
Shares |
12.2 M | 5.1 M | 4.69 M | 3.23 M | 2.92 M | 1.61 M | 1.52 M | 1.45 M | - | - | - | - | - |
Historical Prices |
0.13 | 1.9 | 7.87 | 36.6 | 9.17 | 17.8 | 59.4 | 34.2 | - | - | - | - | - |
Net Income |
-17.4 M | 8.03 M | -28.5 M | -17.8 M | -40.4 M | -53.7 M | 6.97 M | -112 M | -59.3 M | -51.1 M | -53.3 M | - | - |
Revenue |
- | 3.11 M | 12.3 M | 4.31 M | 32.4 M | 23.1 M | 14.7 M | 36.4 M | 33.6 M | 45.6 M | 170 K | - | - |
Cost of Revenue |
- | - | - | - | 19.9 M | 11.2 M | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 4.31 M | 12.5 M | 11.9 M | 9.65 M | 12.3 M | 16.7 M | 29.4 M | 170 K | - | - |
Operating Income |
-28.9 M | -28.6 M | -21.4 M | -27.5 M | -41 M | -51.7 M | -53.9 M | -139 M | -61.1 M | - | - | - | - |
Interest Expense |
578 K | -4.03 M | -8.01 M | -1.32 M | -2.1 M | -2.02 M | -1.94 M | -810 K | -237 K | - | - | - | - |
EBITDA |
-28.3 M | -27.7 M | -20.3 M | -26.1 M | -40.4 M | -49.3 M | -50.8 M | -52.6 M | -58.2 M | -49.5 M | -52.7 M | - | - |
Operating Expenses |
- | - | - | -31.8 M | 55.1 M | 63.5 M | 63.6 M | 68.2 M | 77.8 M | 80.9 M | 53.5 M | - | - |
General and Administrative Expenses |
11.8 M | 13.9 M | 14.7 M | 14 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Aptevo Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
10.5 M | 3.52 M | 687 K | 442 K | 286 K | 147 K | 160 K | 6.47 M | 5.09 M | 5.02 M | 4.94 M | 4.9 M | 4.89 M | 4.54 M | 4.42 M | 4.41 M | 3.23 M | 3.23 M | 3.27 M | 3.23 M | 3.23 M | 3.22 M | 1.57 M | 22.8 M | 22.7 M | 22.6 M | 22 M | 21.6 M | 21.4 M | 21.3 M | 20.8 M | 20.3 M | 20.2 M | 20.2 M | 20.2 M | - | 20.2 M | 20.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-5.1 M | -5.88 M | -6.83 M | - | -6.33 M | -7.95 M | 2.77 M | - | -7.64 M | 28 M | -7.7 M | - | -7 M | -7.93 M | -7.26 M | - | -6.79 M | -6.8 M | 2.9 M | - | -6.92 M | -13.3 M | -12 M | - | -12.6 M | -13.1 M | -13.9 M | - | 37.9 M | -11.2 M | -9.94 M | -14.9 M | -71.7 M | -12.8 M | -12.9 M | -17.9 M | -12.7 M | -17.7 M | -11 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | 3.11 M | 3.11 M | 3.11 M | - | 3.1 M | 3.11 M | 2.42 M | - | 1.46 M | 473 K | - | - | 9.01 M | 7.36 M | 7.02 M | - | 5.82 M | 6.83 M | 4.07 M | - | 6.17 M | 10.8 M | 2.14 M | 8.77 M | 2.82 M | 10.2 M | 8.07 M | 8.29 M | 6.56 M | 7.09 M | 11.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.96 M | 5.98 M | 3.85 M | - | 2.44 M | 2.53 M | 1.78 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-5.21 M | -6.02 M | -6.98 M | - | -6.56 M | -8.18 M | -7.76 M | - | -7.78 M | -7.56 M | -5.61 M | - | -4.75 M | -5.72 M | -6.89 M | - | -6.25 M | -6.81 M | -7.62 M | - | -11.5 M | -12.9 M | -11.4 M | - | -12.1 M | -12.4 M | -13.5 M | - | -10.3 M | -14.6 M | -12.1 M | -14.6 M | -90.5 M | -12.8 M | -13 M | -18.5 M | -13.2 M | -18.3 M | -11.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
112 K | 141 K | 149 K | - | 227 K | 230 K | -67 K | - | -25 K | -1.76 M | -2.26 M | - | -2.33 M | -2.34 M | -782 K | - | -702 K | 4 K | -275 K | - | - | -436 K | -579 K | - | - | -700 K | -353 K | - | -436 K | -513 K | -406 K | - | -492 K | -4 K | 80 K | - | 84 K | -18 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -6.88 M | - | - | - | -7.58 M | - | -7.04 M | -7.04 M | -5.37 M | - | -3.86 M | -5.13 M | -6.59 M | - | -5.18 M | -6.04 M | -7.17 M | - | -9.76 M | -11.7 M | -10.9 M | - | -10.3 M | -11.3 M | -12.9 M | - | -7.36 M | -12.9 M | -11.3 M | -14.6 M | -87.6 M | -11.1 M | -12.1 M | -18.5 M | -11.1 M | -17.9 M | -11.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7.28 M | 7.62 M | - | - | 10.4 M | 11.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
2.11 M | 2.38 M | 3.23 M | - | 2.67 M | 2.72 M | 3.59 M | - | 3.31 M | 3.7 M | 3.86 M | - | 3.48 M | 4.11 M | 3.95 M | - | 3.22 M | 2.84 M | 3.62 M | - | 3.86 M | 4.28 M | 4.53 M | - | 6.94 M | 7.02 M | 7.59 M | - | 7.47 M | 8.42 M | 10.1 M | - | 11.1 M | 8.86 M | 9.42 M | - | 8.51 M | 10.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency